Surgical Correction of Moderate Ischemic Mitral Regurgitation

Shaare Zedek Medical Center

Overview

The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.We will compare patients undergoing CABG + mitral repair or CABG only groups. Primary endpoints include late survival. Secondary endpoints include event free survival, symptoms, and echocardiographic outcomes.

Study Type

OBSERVATIONAL

Conditions

Moderate Ischemic Mitral Regurgitation

Interventions

mitral valve annuloplastyPROCEDURE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients undergoing coronary bypass surgery who have moderate degree of ischemic MR Exclusion Criteria: * etiology of mitral regurgitation other than ischemic, degree of regurgitation other than moderate.

Locations (1)

Shaare Zedek Medical Center

Jerusalem, Israel

Outcomes

Primary Outcomes

survival at 1,5 and 10 years

Secondary Outcomes

event free survival

symptoms

echocardiographic parameters

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.